Indantadol
- Generic Name
- Indantadol
- Drug Type
- Small Molecule
- Chemical Formula
- C11H14N2O
- CAS Number
- 202844-10-8
- Unique Ingredient Identifier
- Z3867B9SQP
- Background
Indantadol has been used in trials studying the treatment of Cough and Diabetic Peripheral Neuropathic Pain.
Phase II Open-Label Pilot Study of V3381 in Chronic Cough
Phase 2
Terminated
- Conditions
- Cough
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2011-07-25
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT01401673
- Locations
- π¬π§
South Manchester University Hospital, Manchester, United Kingdom
Study of the Safety, Tolerability and Efficacy of V3381 in Patients With Diabetic Peripheral Neuropathic Pain
- First Posted Date
- 2008-11-20
- Last Posted Date
- 2016-06-03
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 161
- Registration Number
- NCT00794430
- Locations
- π¨πΏ
Nemocnice Ceske Budejovice, Ceske Budejovice, Czech Republic
π¬π§Royal Infirmary of Edinburgh, Edinburgh, Scotland, United Kingdom
π¨πΏNeurologicke oddeleni, Pardubice, Czech Republic
A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain
Phase 2
Completed
- Conditions
- PainDiabetic Neuropathies
- First Posted Date
- 2006-09-13
- Last Posted Date
- 2007-04-02
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 50
- Registration Number
- NCT00375960
- Locations
- π¨π¦
LMC Endocrinology Centres Ltd., Thornhill, Ontario, Canada
πΊπΈDiablo Clinical Research, Inc., Walnut Creek, California, United States
πΊπΈClinical Research of West Florida, Inc., Clearwater, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath